Spanish researchers have achieved a groundbreaking success in the fight against acute lymphoblastic B-cell leukemia. A new immunotherapy called CAR-STAb, developed in Spain, has proven to be extremely promising in preclinical studies. This development could open up a new treatment perspective, especially for children suffering from the most common form of childhood cancer.
